WO1996030370A3 - Derives de thiazole et de thiadiazole, leur preparation et compositions pharmaceutiques utiles pour le traitement de la thrombocytopenie - Google Patents
Derives de thiazole et de thiadiazole, leur preparation et compositions pharmaceutiques utiles pour le traitement de la thrombocytopenie Download PDFInfo
- Publication number
- WO1996030370A3 WO1996030370A3 PCT/JP1996/000773 JP9600773W WO9630370A3 WO 1996030370 A3 WO1996030370 A3 WO 1996030370A3 JP 9600773 W JP9600773 W JP 9600773W WO 9630370 A3 WO9630370 A3 WO 9630370A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thrombocytopenia
- thiazole
- preparation
- treatment
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU50153/96A AU5015396A (en) | 1995-03-27 | 1996-03-26 | Thiazole and thiadiazole derivatives, their preparation and pharmaceutical compositions useful in the treatment of throm bocytopenia |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9506189.1 | 1995-03-27 | ||
GBGB9506189.1A GB9506189D0 (en) | 1995-03-27 | 1995-03-27 | Thiazole derivatives,process for production thereof and pharmaceutical compositions comprising the same |
GBGB9511226.4A GB9511226D0 (en) | 1995-06-02 | 1995-06-02 | Heterocyclic compounds processes for production thereof and pharmaceutical compositions comprising the same |
GB9511226.4 | 1995-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996030370A2 WO1996030370A2 (fr) | 1996-10-03 |
WO1996030370A3 true WO1996030370A3 (fr) | 1996-11-28 |
Family
ID=26306753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/000773 WO1996030370A2 (fr) | 1995-03-27 | 1996-03-26 | Derives de thiazole et de thiadiazole, leur preparation et compositions pharmaceutiques utiles pour le traitement de la thrombocytopenie |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5015396A (fr) |
IL (1) | IL117620A0 (fr) |
WO (1) | WO1996030370A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9040548B2 (en) | 1999-11-05 | 2015-05-26 | Astrazeneca Ab | Quinazoline derivatives as VEGF inhibitors |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK285141B6 (sk) | 1996-02-13 | 2006-07-07 | Astrazeneca Uk Limited | Použitie chinazolínového derivátu, chinazolínový derivát, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje |
EP0885198B1 (fr) | 1996-03-05 | 2001-12-19 | AstraZeneca AB | Derives de 4-anilinoquinazoline |
GB9707800D0 (en) | 1996-05-06 | 1997-06-04 | Zeneca Ltd | Chemical compounds |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
ATE300521T1 (de) | 1996-09-25 | 2005-08-15 | Astrazeneca Ab | Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern |
ES2289791T3 (es) | 1997-08-22 | 2008-02-01 | Astrazeneca Ab | Derivados de oxindolilquinazolina como inhibidores de la angiogenesis. |
US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
DK1119567T3 (da) | 1998-10-08 | 2005-07-25 | Astrazeneca Ab | Quinazolinderivater |
US6414156B2 (en) | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
US6214852B1 (en) | 1998-10-21 | 2001-04-10 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
JP2002534512A (ja) * | 1999-01-15 | 2002-10-15 | ノボ ノルディスク アクティーゼルスカブ | 非ペプチドglp−1アゴニスト |
US6927214B1 (en) | 1999-01-15 | 2005-08-09 | Novo Nordisk A/S | Non-peptide GLP-1 agonists |
US6392053B2 (en) | 1999-12-15 | 2002-05-21 | Bristol-Myers Squibb Company | Process for preparing arylacetylaminothiazoles |
US6515004B1 (en) | 1999-12-15 | 2003-02-04 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
US7160889B2 (en) | 2000-04-07 | 2007-01-09 | Astrazeneca Ab | Quinazoline compounds |
PL360439A1 (en) * | 2000-06-28 | 2004-09-06 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors |
BR0113056A (pt) | 2000-08-09 | 2003-07-08 | Astrazeneca Ab | Composto, processo papa a preparação do mesmo, composição farmacêutica, e, método para produzir um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente, e, uso de um composto |
CN104003956A (zh) * | 2013-02-27 | 2014-08-27 | 中国药科大学 | 噻唑类化合物、其制备方法与其在制药中的用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105767A (en) * | 1977-03-28 | 1978-08-08 | Merck & Co., Inc. | Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group |
EP0412404A2 (fr) * | 1989-08-07 | 1991-02-13 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de thiazole, procédé et compositions pharmaceutiques les contenant |
EP0422369A2 (fr) * | 1989-09-07 | 1991-04-17 | Bayer Ag | Carbamoyltriazoles substitués |
-
1996
- 1996-03-22 IL IL11762096A patent/IL117620A0/xx unknown
- 1996-03-26 WO PCT/JP1996/000773 patent/WO1996030370A2/fr active Application Filing
- 1996-03-26 AU AU50153/96A patent/AU5015396A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105767A (en) * | 1977-03-28 | 1978-08-08 | Merck & Co., Inc. | Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group |
EP0412404A2 (fr) * | 1989-08-07 | 1991-02-13 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de thiazole, procédé et compositions pharmaceutiques les contenant |
EP0422369A2 (fr) * | 1989-09-07 | 1991-04-17 | Bayer Ag | Carbamoyltriazoles substitués |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, vol. 40, no. 10, 1946, Columbus, Ohio, US; DAHLBOM ET AL.: "Sulfides and sulfones containing ..." page 4061; column 1; XP002005555 * |
LAGORCE ET AL.: "Synthesis and Antithyroid activity ...", CHEM. PHARM. BULL., vol. 41, no. 7, 1993, pages 1258 - 1260, XP002005554 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9040548B2 (en) | 1999-11-05 | 2015-05-26 | Astrazeneca Ab | Quinazoline derivatives as VEGF inhibitors |
Also Published As
Publication number | Publication date |
---|---|
AU5015396A (en) | 1996-10-16 |
IL117620A0 (en) | 1996-07-23 |
WO1996030370A2 (fr) | 1996-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996030370A3 (fr) | Derives de thiazole et de thiadiazole, leur preparation et compositions pharmaceutiques utiles pour le traitement de la thrombocytopenie | |
IL124537A0 (en) | Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same | |
AU1200695A (en) | 4,5-diaryloxazole derivatives | |
AU635758B2 (en) | Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same | |
GR3032311T3 (en) | Stilbene derivatives and pharmaceutical compositions containing them | |
AU4869690A (en) | Pyrazolopyridine compound and processes for preparation thereof | |
MX9800577A (es) | Derivados de 4,5-diaril oxazol. | |
MD1233C2 (ro) | Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora | |
AU8046891A (en) | Pyrazolopyridine compound and processes for preparation thereof | |
CA2275166A1 (fr) | Nouveaux derives de benzopyrane | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
IL109615A0 (en) | Polypeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
AU1614492A (en) | New peptide compound and a process for the preparation thereof | |
AU2692792A (en) | Oxazolidone derivative | |
CA2204204A1 (fr) | Derives de glucides | |
AU8226891A (en) | Benzopyran derivative, production thereof, and pharmaceutical composition containing the same | |
MY110004A (en) | Biologically active ureido derivatives useful as antimetastatic agents. | |
AU4375389A (en) | Pyrrolidine derivatives | |
CA2105977A1 (fr) | Composition a base de sulfoxyde de thiocarbamate pour neutraliser l'ethanol ingere | |
EP0739894A4 (fr) | Derive de thiazoline | |
EP0394476A4 (en) | Novel 1,3,4-thiadiazole derivatives and antiulcer agents containing same as active ingredient | |
MX9707673A (es) | Derivados de ureido biologicamente activos, eficaces en el tratamiento de la esclerosis multiple. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA CN HU JP KR NO US AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA CN HU JP KR NO US AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |